Lucas Pereira Azevedo
Research Subjects
Lucas Pereira Azevedo has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Thales Guilherme Silva Campos1 shared publication
Áppia Larissa Ribeiro Costa
1 shared publicationÁvila Clicia Ribeiro Costa
1 shared publication
Latest Publications
- 23 November 2025
- Published by Revista ft Ltda in Revista ft
- Vol. 29 (152) , 43-44
FARMACOVIGILÂNCIA NO BRASIL: DESAFIOS, AVANÇOS E O PAPEL TRANSFORMADOR DO FARMACÊUTICO NA SEGURANÇA DO PACIENTE
Pharmacovigilance is a key strategy for promoting patient safety and enhancing the quality of pharmaceutical care. This study aimed to analyze the challenges, advances, and the transformative role of pharmacists in pharmacovigilance in Brazil, through an integrative literature review. Articles published between 2020 and 2025 in Portuguese, English, and Spanish were selected from recognized databases such as PubMed, SciELO, LILACS, and BVS. The critical analysis of the studies revealed that, despite regulatory progress and the implementation of systems like VigiMed, underreporting of adverse drug reactions (ADRs) remains a significant barrier. Pharmacists, due to their clinical role and direct contact with patients, play a strategic role in the early identification of ADRs, guidance on safe medication use, and the promotion of a patient-centered care culture. The literature emphasizes that educational interventions and multidisciplinary team integration are essential to strengthening pharmacovigilance. It is concluded that the advancement of this practice depends on continuous education, institutional support, and the recognition of pharmacists as key agents in patient safety.
- 23 November 2025
- Published by Revista ft Ltda in Revista ft
- Vol. 29 (152) , 43-44
FARMACOVIGILÂNCIA NO BRASIL: DESAFIOS, AVANÇOS E O PAPEL TRANSFORMADOR DO FARMACÊUTICO NA SEGURANÇA DO PACIENTE
Pharmacovigilance is a key strategy for promoting patient safety and enhancing the quality of pharmaceutical care. This study aimed to analyze the challenges, advances, and the transformative role of pharmacists in pharmacovigilance in Brazil, through an integrative literature review. Articles published between 2020 and 2025 in Portuguese, English, and Spanish were selected from recognized databases such as PubMed, SciELO, LILACS, and BVS. The critical analysis of the studies revealed that, despite regulatory progress and the implementation of systems like VigiMed, underreporting of adverse drug reactions (ADRs) remains a significant barrier. Pharmacists, due to their clinical role and direct contact with patients, play a strategic role in the early identification of ADRs, guidance on safe medication use, and the promotion of a patient-centered care culture. The literature emphasizes that educational interventions and multidisciplinary team integration are essential to strengthening pharmacovigilance. It is concluded that the advancement of this practice depends on continuous education, institutional support, and the recognition of pharmacists as key agents in patient safety.